— We are Neobe Theraputics
Transforming cancer treatment through engineered live biotherapeutics
Who are NEOBE?
We are building a synthetic biology platform to design programmable microbial trojan horses engineered to disrupt the microenvironment of solid tumours, enabling immunotherapy success in patients with immune excluded tumours.
Research backed by leading scientific partners
Real therapeutic breakthroughs come when likeminded innovators work together to drive patient benefits. Our collaborative programmes with leading academics in synbio and immunology are integral to the core of our technology. We are backed by visionary investors who support us in our vision to enable therapeutic efficacy through next generation engineered live biotherapeutics.
Meet the dedicated team of scientists behind our research
Neobe’s leadership has decades of combined experience in cancer biology, advanced therapies and bacterial engineering, supported by recognized leaders in oncology business development. Our world class R&D team is committed to a culture of collaboration and inclusion, working together to bring our engineered LBPs to the clinic.
